Replimune is a clinical-stage biotech developing oncolytic virus therapies for cancer. This page tracks what's actually moving the stock — FDA decisions, analyst calls, and trial results — updated as it develops.
US markets live · August 9, 2026
Material developments only. Each item passed independent evidence and Google News compliance checks.
Vistra is one of the largest independent power producers in the US, and its stock has become a proxy for the AI-driven surge in electricity demand. This page tracks what's actually moving the stock, updated as it develops.